MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
AKBA — Akebia Therapeutics, Inc.
NasdaqAkebia Therapeutics, Inc.
$0.87
-0.05(-5.33%)
- O
- 0.91
- H
- 0.92
- L
- 0.87
- V
- 4.5M
⏱️ End-of-day dataAs of Oct 1, 2026
AKBA — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $16.26M | $18.48M | $16.64M | $13.73M | N/A | N/A |
| Accounts Receivable | $62.54M | $47.03M | $66.22M | $72.81M | $61.54M | $34.37M |
| Inventory | $13.00M | $15.61M | $18.64M | $16.71M | N/A | N/A |
| Restricted Cash | $1.70M | $1.70M | $1.70M | N/A | N/A | N/A |
| Other Current Assets | $3.60M | $3.77M | $5.33M | $7.83M | N/A | N/A |
| Total Current Assets | $24.35M | $25.30M | $25.83M | $23.47M | N/A | N/A |
| Properties | $3.42M | $4.88M | $6.31M | $7.70M | N/A | N/A |
| Goodwill | $11.81M | $11.81M | $11.81M | $11.81M | N/A | N/A |
| Other Non Current Assets | $56.57M | $59.68M | $40.46M | $44.19M | N/A | N/A |
| Total Non Current Assets | $11.90M | $12.36M | $10.58M | $11.09M | N/A | N/A |
| Total Assets | $36.25M | $37.66M | $36.42M | $34.56M | N/A | N/A |
| Accounts Payable | $8.39M | $21.18M | $10.09M | $11.55M | N/A | N/A |
| Accrued Expenses | $23.09M | $22.70M | $74.33M | $60.28M | N/A | N/A |
| Short Term Debt | $14.62M | $3.55M | $4.94M | $5.63M | N/A | N/A |
| Deferred Revenue | $4.50M | $2.68M | $3.88M | $5.53M | N/A | N/A |
| Pensions | $8.32M | $11.02M | $9.31M | $6.75M | N/A | N/A |
| Other Current Liabilities | $99.63M | $86.52M | $16.78M | $12.42M | N/A | N/A |
| Total Current Liabilities | $17.39M | $16.29M | $13.34M | $11.87M | N/A | N/A |
| Long Term Provisions | $16.41M | $22.61M | $27.73M | $30.56M | N/A | N/A |
| Long Term Debt | $36.40M | $48.25M | $47.64M | $47.73M | N/A | N/A |
| Derivative Product Liabilities | $2.52M | $2.98M | $5.24M | $14.20M | N/A | N/A |
| Other Non Current Liabilities | $10.59M | $10.72M | $10.86M | $10.52M | N/A | N/A |
| Total Non Current Liabilities | $16.13M | $18.10M | $18.92M | $19.77M | N/A | N/A |
| Total Liabilities | $33.51M | $34.40M | $32.26M | $31.64M | N/A | N/A |
| Common Stock | 2,000.00 | 2,000.00 | 2,000.00 | 2,000.00 | N/A | N/A |
| Retained Earnings | $-169.28M | $-168.37M | $-167.15M | $-167.20M | N/A | N/A |
| Other Shareholders Equity | 6,000.00 | 6,000.00 | 6,000.00 | 6,000.00 | N/A | N/A |
| Total Shareholders Equity | $27.38M | $32.61M | $41.59M | $29.22M | N/A | N/A |
| Additional Paid In Capital | $172.01M | $171.63M | $171.30M | $170.12M | N/A | N/A |
| Prepaid Assets | N/A | 0.00 | 0.00 | 0.00 | N/A | N/A |